Abstract
Introduction Urinary pteridines are putative molecular biomarkers for noninvasive cancer screening and prognostication. Central to their translational biomarker development is the need to understand the sources and extent of their non-epidemiological variation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have